These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 2854065)

  • 21. Combined evaluation of myocardial perfusion and coronary morphology in the identification of subclinical CAD. Radiation exposure of 13N-ammonia PET/CT.
    Vincenti G; Quercioli A; Zaïdi H; Nkoulou R; Dewarrat S; Rager O; Ambrosio G; Seimbille Y; Mach F; Ratib O; Schindler TH
    Nuklearmedizin; 2010; 49(5):173-82. PubMed ID: 20664888
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of FDG-PET in the evaluation and staging of hepatocellular carcinoma with comparison of tumor size, AFP level, and histologic grade.
    Wolfort RM; Papillion PW; Turnage RH; Lillien DL; Ramaswamy MR; Zibari GB
    Int Surg; 2010; 95(1):67-75. PubMed ID: 20480845
    [TBL] [Abstract][Full Text] [Related]  

  • 23. FDG positron emission tomography in the surveillance of hepatic tumors treated with radiofrequency ablation.
    Anderson GS; Brinkmann F; Soulen MC; Alavi A; Zhuang H
    Clin Nucl Med; 2003 Mar; 28(3):192-7. PubMed ID: 12592125
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A dynamic study of rectally absorbed ammonia in liver cirrhosis using [13N]ammonia and a positron camera.
    Koen H; Okuda K; Musha H; Tateno Y; Fukuda N; Matsumoto T; Shisido F; Rikitake T; Iinuma T; Kurisu A; Arimizu N
    Dig Dis Sci; 1980 Nov; 25(11):842-8. PubMed ID: 7438957
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Validation of nitrogen-13-ammonia tracer kinetic model for quantification of myocardial blood flow using PET.
    Muzik O; Beanlands RS; Hutchins GD; Mangner TJ; Nguyen N; Schwaiger M
    J Nucl Med; 1993 Jan; 34(1):83-91. PubMed ID: 8418276
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Assessment of [(18)F]-fluoroacetate PET/CT as a tumor-imaging modality: preclinical study in healthy volunteers and clinical evaluation in patients with liver tumor.
    Takemoto K; Hatano E; Nishii R; Kagawa S; Kishibe Y; Takahashi M; Yamauchi H; Matsumura K; Zaima M; Toriguchi K; Tanabe K; Kitamura K; Seo S; Taura K; Endo K; Uemoto S; Higashi T
    Ann Nucl Med; 2014 May; 28(4):371-80. PubMed ID: 24599824
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Posterolateral defect of the normal human heart investigated with nitrogen-13-ammonia and dynamic PET.
    de Jong RM; Blanksma PK; Willemsen AT; Anthonio RL; Meeder JG; Pruim J; Vaalburg W; Lie KI
    J Nucl Med; 1995 Apr; 36(4):581-5. PubMed ID: 7699445
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Quantitative measurement of regional myocardial blood flow in patients with coronary artery disease by intravenous injection of 13N-ammonia in positron emission tomography.
    Hara T; Michihata T; Yokoi F; Sakamoto S; Masuoka T; Iio M
    Eur J Nucl Med; 1990; 16(4-6):231-5. PubMed ID: 2351171
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Assessment of global and regional left ventricular function by electrocardiographic gated N-13 ammonia positron emission tomography in patients with coronary artery disease.
    Kanayama S; Matsunari I; Hirayama A; Kitayama M; Matsudaira M; Yoneyama T; Nekolla SG; Hisada K; Kajinami K; Takekoshi N
    Circ J; 2005 Feb; 69(2):177-82. PubMed ID: 15671609
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Positron CT imaging with 13N-ammonia and 11C-carbon monoxide in intracranial tumors].
    Shishido F; Tateno Y; Yamasaki T; Irie T; Inoue O; Tamate K; Suzuki K; Nakayama T; Takashima T; Yamaura A; Kurisu A; Ikehira H
    Kaku Igaku; 1982 Aug; 19(7):1035-8. PubMed ID: 6983613
    [No Abstract]   [Full Text] [Related]  

  • 31. Direct comparison of [13N]ammonia and [15O]water estimates of perfusion with quantification of regional myocardial blood flow by microspheres.
    Bol A; Melin JA; Vanoverschelde JL; Baudhuin T; Vogelaers D; De Pauw M; Michel C; Luxen A; Labar D; Cogneau M
    Circulation; 1993 Feb; 87(2):512-25. PubMed ID: 8425298
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Value of rest-stress myocardial positron tomography using nitrogen-13 ammonia for the preoperative prediction of reversible asynergy.
    Tamaki N; Yonekura Y; Yamashita K; Senda M; Saji H; Konishi Y; Hirata K; Ban T; Konishi J
    J Nucl Med; 1989 Aug; 30(8):1302-10. PubMed ID: 2787845
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of PERCIST and RECIST criteria for evaluation of therapy response after yttrium-90 microsphere therapy in patients with hepatocellular carcinoma and those with metastatic colorectal carcinoma.
    Sager S; Akgün E; Uslu-Beşli L; Asa S; Akovali B; Sahin O; Yeyin N; Demir M; Abuqbeitah M; Gülsen F; Sayman H; Sönmezoglu K
    Nucl Med Commun; 2019 May; 40(5):461-468. PubMed ID: 30896544
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Quantification of myocardial blood flow using 13N-ammonia and PET: comparison of tracer models.
    Choi Y; Huang SC; Hawkins RA; Kim JY; Kim BT; Hoh CK; Chen K; Phelps ME; Schelbert HR
    J Nucl Med; 1999 Jun; 40(6):1045-55. PubMed ID: 10452323
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rectal 13N-ammonia test (13N-liver/heart ratio), hepatic sinusoidal pressure and prevailing portal flow direction in cirrhosis of the liver.
    Hazenberg HJ; Gips CH; Beekhuis H; Kruizinga K
    Acta Hepatogastroenterol (Stuttg); 1976; 23(5):319-27. PubMed ID: 983660
    [TBL] [Abstract][Full Text] [Related]  

  • 36. PET Imaging of cerebral astrocytoma with 13N-ammonia.
    Xiangsong Z; Changhong L; Weian C; Dong Z
    J Neurooncol; 2006 Jun; 78(2):145-51. PubMed ID: 16739028
    [TBL] [Abstract][Full Text] [Related]  

  • 37. (4S)-4-(3-18F-fluoropropyl)-L-glutamate for imaging of xC transporter activity in hepatocellular carcinoma using PET: preclinical and exploratory clinical studies.
    Baek S; Mueller A; Lim YS; Lee HC; Lee YJ; Gong G; Kim JS; Ryu JS; Oh SJ; Lee SJ; Bacher-Stier C; Fels L; Koglin N; Schatz CA; Dinkelborg LM; Moon DH
    J Nucl Med; 2013 Jan; 54(1):117-23. PubMed ID: 23232273
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Vascularization of liver tumors - preliminary results with Coded Harmonic Angio (CHA), phase inversion imaging, 3D power Doppler and contrast medium-enhanced B-flow with second generation contrast agent (Optison).
    Jung EM; Kubale R; Jungius KP; Jung W; Lenhart M; Clevert DA
    Clin Hemorheol Microcirc; 2006; 34(4):483-97. PubMed ID: 16687788
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 13N-Ammonia PET/CT for detection of recurrent glioma: a prospective comparison with contrast-enhanced MRI.
    Khangembam BC; Sharma P; Karunanithi S; Singhal A; Das CJ; Kumar P; Julka PK; Bandopadhyaya GP; Kumar R; Malhotra A; Bal C
    Nucl Med Commun; 2013 Nov; 34(11):1046-54. PubMed ID: 24025920
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Iodine quantification to distinguish hepatic neuroendocrine tumor metastasis from hepatocellular carcinoma at dual-source dual-energy liver CT.
    Kaltenbach B; Wichmann JL; Pfeifer S; Albrecht MH; Booz C; Lenga L; Hammerstingl R; D'Angelo T; Vogl TJ; Martin SS
    Eur J Radiol; 2018 Aug; 105():20-24. PubMed ID: 30017280
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.